Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.
Fang E, Wang X, Wang J, Hu A, Song H, Yang F, Li D, Xiao W, Chen Y, Guo Y, Liu Y, Li H, Huang K, Zheng L, Tong Q.
Fang E, et al. Among authors: li d, li h.
Theranostics. 2020 Jan 1;10(4):1555-1571. doi: 10.7150/thno.37383. eCollection 2020.
Theranostics. 2020.
PMID: 32042322
Free PMC article.